COMMUNIQUÉS West-GlobeNewswire

ArriVent BioPharma Reports First Quarter 2026 Financial Results
11/05/2026
Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected mid-2026 IND clearance of ARR-002, ArriVent’s dual-targeting MUC16/NaPi2b tetravalent ADC, advances into [...]
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
11/05/2026
SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it [...]
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/05/2026
ZUG, Switzerland, May 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs [...]
LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
11/05/2026
Q1 2026 total revenue of $1.9 million, including $1.7 million in VIZZ ® product sales Approximately 46,000 paid prescriptions filled and over 10,000 prescribing eye care professionals from launch through Q1 2026 [...]
Outset Medical to Present at RBC Global Healthcare Conference
11/05/2026
SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less [...]
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
11/05/2026
On track for regulatory submission of MGX-001 to advance global clinical program, including investigational new drug application (“IND”) in 4Q 2026 Publication in Nature Structural & Molecular Biology highlights [...]
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
11/05/2026
Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7% Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; [...]
Sotera Health Announces Secondary Offering of Common Stock
11/05/2026
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0. [...]
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
11/05/2026
Announced two-trial clinical development strategy for AKY-2519 enabling evaluation in multiple patient segments Initiated Phase 1b clinical trial of AKY-2519 in metastatic castration-resistant prostate cancer (mCRPC); [...]
Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights
11/05/2026
Phase 3 CoMpass trial advancing toward enrollment completion, supporting 2H 2027 topline data Natalie Holles appointed Chief Executive Officer and President and member of the Board of Directors Strengthened balance [...]
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
11/05/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 11, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
De jeunes leaders transmettent des compétences qui sauvent des vies aux élèves du primaire : Le programme de RCR et DEA au secondaire d’ACT en action
11/05/2026
BRAMPTON, Ontario, 11 mai 2026 (GLOBE NEWSWIRE) -- Des élèves leaders de l’école secondaire Jean Augustine ont initié plus de 100 élèves de 8ème année de l’école publique Eldorado à la réanimation cardiorespiratoire ( [...]
GENFIT : Assemblée Générale Mixte du 15 juin 2026 — modalités de mise à disposition des documents préparatoires
11/05/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 11 mai 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares [...]
Human Appeal Launches Global Step Challenge, Turning Steps into Worship and a Lifeline for Families this Hajj
11/05/2026
Participants challenged to walk 10,000 steps a day during the 10 most sacred days of the Islamic Calendar, raising funds to deliver vital meals to those in need Key Takeaways: Global Initiative Launch: Global [...]
Youth Leaders Empowering Young Students with Lifesaving Skills: ACT High School CPR Program in Action
11/05/2026
BRAMPTON, Ontario, May 11, 2026 (GLOBE NEWSWIRE) -- Leadership students from Jean Augustine Secondary School introduced more than 100 Grade 8 students at Eldorado Public School to lifesaving CPR and AED training. The [...]
Portsmouth Square, Inc. Reports Third Quarter Fiscal 2026 Results; Hotel Operating Results Improve Year‑Over‑Year as San Francisco Recovery Progresses
11/05/2026
Los Angeles, California, May 11, 2026 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (the “Company” or “Portsmouth”) today announced financial results for the fiscal third quarter ended March 31, 2026. Portsmouth’s [...]
110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS
11/05/2026
CONSHOHOCKEN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- May is GBS|CIDP Awareness Month and this year marks 110 years since the discovery of Guillain-Barré syndrome (GBS), which was first identified and named in 1916 by [...]
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
11/05/2026
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief [...]
Pheast Therapeutics Presents Preclinical Data on PHST677, a Novel Bispecific ADC Targeting CDH1 and Nectin-4 at PEGS Boston Summit 2026
11/05/2026
Preclinical data demonstrate a differentiated bispecific ADC design through E-cadherin blockade and Nectin-4 targeting REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Pheast Therapeutics , a clinical-stage [...]

Pages